Latest Updates

COVID-19 Vaccine Fact Vs. Fiction: An Expert Weighs in on Common Fears

January 27, 2021
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including B.1.1.7 Variant

January 25, 2021
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.

Severe COVID-19 Disables Disease-Fighting Immune Circuit 

January 25, 2021
Patients with severe COVID-19 produce antibodies that paradoxically shut down their immune system’s virus-fighting response just when they need it most.

Cancer Drug Shows Potent Activity in the Lab Against SARS-CoV-2, Including New Variants

January 25, 2021
In two preclinical models of COVID-19, plitidepsin showed a 100-fold reduction in viral replication in the lungs and demonstrated an ability to reduce lung inflammation.

COVID-19 Variant First Found in Other Countries and States Now Seen More Frequently in California

January 19, 2021
“It’s too soon to know if this variant will spread more rapidly than others," said Erica Pan, MD, MPH, State Epidemiologist for the California Department of Public Health.

Virus Versus Virus: ‘ReScan’ Antibody Test is a Powerful New Tool

January 13, 2021
Scientists at UCSF have developed ReScan, an innovative new serological test that employs a specialized version of the technique known as phage display.

How Worried Should You Be About the New Coronavirus Variant?

January 12, 2021
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.

UCSF Administers Second Dose of COVID-19 Vaccine to Frontline Staff 

January 08, 2021
UCSF Medical Center has begun administering second doses of the Pfizer COVID-19 vaccine to frontline employees who are at highest risk of exposure to COVID-19 at work. 

Seniors Living Alone with Cognitive Impairment Hit Hard by COVID-19 Pandemic 

January 06, 2021
Researchersare calling for tailored services and support for older adults living alone with memory issues, who are experiencing extreme isolation, and are exposed to misinformation about the virus and barriers to accessing medical care.  

Vaccination Begins at UCSF – A Watershed Moment in COVID-19 Pandemic

December 16, 2020
On a history-making day, UCSF began the first vaccinations of its critical health care workforce, including both clinical and non-clinical staff whose work places them at heightened risk of infection by COVID-19.

Pages